Delivery Order SPE2DB20D3103-SPE2DB23FL4Z0

Award Date 10/31/22
Potential Completion Date 11/1/22
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,516.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EFFEXOR XR 37.5 MG CAPSULE 90S, a prescription medication. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,251.19, is a Firm Fixed Price Delivery Order for the supply of Effexor XR 75 mg capsules. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Effexor XR 37.5 mg capsules. The $4,926.58 firm-fixed-price delivery order has an ultimate completion date of April 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FN1R5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,244.16 delivery order is for the supply of EFFEXOR XR 37.5 MG CAPSULE 90S, a medication used to treat mental health conditions. The contract has a firm fixed price and an ultimate completion date of April 24, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,947.21 firm fixed-price delivery order is for the supply of EFFEXOR XR 150 MG CAPSULE 90S, a prescription medication. The contract has an ultimate completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,963.92, is for the delivery of Effexor XR 37.5 mg capsules to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp is a subsidiary of the...
This is a $3,508.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Effexor XR 75 mg capsules. No set-aside designation was used. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,575.91, is for the delivery of Effexor XR 37.5 mg capsules. This is a firm fixed-price contract with a period of performance through January 13, 2023. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Effexor XR 37.5 mg capsules. The $5,936.15 firm fixed-price delivery order contract has a completion date of May 4, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Effexor XR 37.5 mg capsules. The $5,135.49 firm-fixed-price delivery order has a completion date of June 6, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FL4Z0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,891.91, is for the delivery of Effexor XR 37.5 mg capsules and does not have a set-aside designation.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through streamlined, comprehensive contracting mechanisms.

Generated 2/27/25, 11:13 AM